On ECHEMI
Home > Drugs > Renal tubular acidosis
Renal tubular acidosis
Renal tubular acidosis (RTA) is a metabolic acidosis caused by congenital genetic defects and various secondary factors, resulting in the reabsorption of sodium bicarbonate in the proximal tubules or/and the dysfunction of acid excretion in the distal tubules. The main manifestations are: ① hyperchloremic, normal anion gap (AG) metabolic acidosis; ② electrolyte disorders; ③ bone disease; ④ urinary tract symptoms. Most patients do not have glomerular abnormalities. In some genetic diseases, RTA may be the main or only clinical manifestation. This group of diseases is divided into primary and secondary according to the cause; divided into complete and incomplete according to whether systemic metabolic acidosis occurs; and divided into proximal and distal RTA according to the main site of renal tubular involvement. At present, a comprehensive classification based on the site of lesions, pathophysiological changes and clinical manifestations is often used: type 1, distal RTA; type 2, proximal RTA; type 3, with the characteristics of both type 1 and type 2 RTA; type 4, hyperkalemic RTA.
  • Site of disease:

    kidney
  • Infectious :

    Not contagious
  • Frequent population:

    Most common in children and young people
  • Related symptoms:

    Increased phosphate excretion in urine polyuria nausea and vomiting bone pain loss of appetite
  • Concurrent disease:

Related Drugs
Potassium Citrate Sustained Release Tablets
Indication: This product is used for renal tubular acidosis with calcium stones, hypocitraturic calcium oxalate kidney stones caused by any cause, and uric acid stones with or without calcium stones.
Manufacturer:

Livzon (GROUP) Pharmaceutical FACTORY

Furosemide
Indication: 1. Edema diseases: including congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons); 2. Hypertension; 3. Combined use when rapid diuresis is necessary for cerebral/pulmonary edema; 4. Severe hypercalcemia, combined with water supplementation.
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Furosemide
Indication: 1. Edema diseases: including congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons); 2. Hypertension; 3. Combined use when rapid diuresis is necessary for cerebral/pulmonary edema; 4. Severe hypercalcemia, combined with water supplementation.
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Furosemide
Indication: 1. Edema diseases: including congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons); 2. Hypertension; 3. Combined use when rapid diuresis is necessary for cerebral/pulmonary edema; 4. Severe hypercalcemia, combined with water supplementation.
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Furosemide
Indication: 1. Edema diseases: including congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons); 2. Hypertension; 3. Combined use when rapid diuresis is necessary for cerebral/pulmonary edema; 4. Severe hypercalcemia, combined with water supplementation.
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Furosemide
Indication: 1. Edema diseases: including congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons); 2. Hypertension; 3. Combined use when rapid diuresis is necessary for cerebral/pulmonary edema; 4. Severe hypercalcemia, combined with water supplementation.
Manufacturer:

Beijing Taiyang Pharmaceutical Industry Co., Ltd.

Furosemide
Indication: 1. Edema diseases: including congestive heart failure, liver cirrhosis, kidney disease (nephritis, nephropathy and acute and chronic renal failure caused by various reasons); 2. Hypertension; 3. Combined use when rapid diuresis is necessary for cerebral/pulmonary edema; 4. Severe hypercalcemia, combined with water supplementation.
Manufacturer:

Changzhou Yabang Pharmaceutical Co., Ltd.

Compound Sodium Bicarbonate Tablets
Indication: It is used to alkalinize urine and acidemia, and can also be used for excessive gastric acid.
Manufacturer:

Sinopharm Medicine Holding Xingsha Pharmaceutical (Xiamen) Co., Ltd.

Compound Sodium Bicarbonate Tablets
Indication: It is used to alkalinize urine and acidemia, and can also be used for excessive gastric acid.
Manufacturer:

Fuzhou FU Yao Pharmaceutical Co., Ltd.

SODIUM CITRATE AND CITRIC ACID- sodium citrate and citric acid monohydrate_solution
Indication: Sodium Citrate and Citric Acid Oral Solution USP is an effective alkalinizing agent. It is useful in those conditions where long-term maintenance of an alkaline urine is desirable, and is of value in the alleviation of chronic metabolic acidosis, such as results from chronic renal insufficiency or the syndrome of renal tubular acidosis, especially when the administration of potassium salts is undesirable or contraindicated. This product is also useful for buffering and neutralizing gastric hydrochloric acid quickly and effectively. Sodium Citrate and Citric Acid Oral Solution USP is concentrated, and when administered after meals and before bedtime, allows one to maintain an alkaline urinary pH around the clock, usually without the necessity of a 2 A.M. dose. This product alkalinizes the urine without producing a systemic alkalosis in the recommended dosage. This product is highly palatable, pleasant tasting, and tolerable, even when administered for long periods.
Manufacturer:

MAJOR® PHARMACEUTICALS

  • 1
  • 2
  • Go to Page Go
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.